PRODUCTS

INTERNATIONAL  /  EXENATIDE LAI «  BACK TO "INTERNATIONAL"

Exenatide is a glucagon-like peptide-1 (GLP-1) receptor agonist that exhibits several antihyperglycaemic actions of glucagon-like peptide-1 (GLP-1).
It is indicated for treatment of type 2 diabetes mellitus in combination with: metformin, sulphonylureas, thiazolidinediones, metformin and a sulphonylurea, metformin and a thiazolidinedione in adults who have not achieved adequate glycaemic control on maximally tolerated doses of these oral therapies.
It is also indicated as adjunctive therapy to basal insulin with or without metformin and/or pioglitazone in adults who have not achieved adequate glycaemic control with these agents.
Under Development
Active ingredient Pharmaceutical form Package Therapeutic target
  • Exenatide LAI
  • Long-Acting Injectable
  • 2mg/vial
  • Antidiabetic

Other products in "International"